The Optimal Cutoff Value of ApolipoproteinB/ApolipoproteinA-I Ratio for the Diagnosis of Metabolic Syndrome and Insulinresistance in the Population of Georgia
Keywords:
Keywords, ApoB/ApoA-I ratio, cutoff value, insulin resistance, metabolic syndromeAbstract
Studies have indicated that ApoB/ApoA-I ratio is significantly associated with MetS and IR. This study was designedto assess the optimal cutoff values of ApolipoproteinB/ApolipoproteinA-I (ApoB/ApoA-I) ratio for the diagnosis of metabolic syndrome
References
"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)," Jama, vol. 285, pp. 2486-97, May 16 2001.
K. G. Alberti, P. Zimmet, and J. Shaw, "Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation," Diabet Med, vol. 23, pp. 469-80, May 2006.
K. G. Alberti and P. Z. Zimmet, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation," Diabet Med, vol. 15, pp. 539-53, Jul 1998.
A. A. Alfadda, N. M. Al-Daghri, and U. H. Malabu, "Apolipoprotein B/apolipoprotein A-I ratio in relation to various definitions of metabolic syndrome among Saudi patients with type 2 diabetes mellitus," Saudi Med J, vol. 29, pp. 821-5, Jun 2008.
B. Antuna-Puente, M. Faraj, A. D. Karelis, D. Garrel, D. Prud'homme, R. Rabasa-Lhoret, et al., "HOMA or QUICKI: is it useful to test the reproducibility of formulas?," Diabetes Metab, vol. 34, pp. 294-6, Jun 2008.
J. F. Ascaso, P. Romero, J. T. Real, A. Priego, C. Valdecabres, and R. Carmena, "[Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population]," Med Clin (Barc), vol. 117, pp. 530-3, Nov 3 2001.
M. P. Bahillo-Curieses, F. Hermoso-Lopez, M. J. Martinez-Sopena, P. Cobreros-Garcia, P. Garcia-Saseta, M. Triguez-Garcia, et al., "Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents," Endocrine, vol. 41, pp. 289-95, Apr 2012.
G. Bednarek-Tupikowska, B. Stachowska, T. Miazgowski, B. Krzyzanowska-Swiniarska, B. Katra, M. Jaworski, et al., "Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population," Endokrynol Pol, vol. 63, pp. 447-55, 2012.
H. Belfki, S. Ben Ali, S. Bougatef, D. Ben Ahmed, N. Haddad, A. Jmal, et al., "The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population," Exp Mol Pathol, vol. 91, pp. 622-5, Oct 2011.
R. H. Eckel, K. G. Alberti, S. M. Grundy, and P. Z. Zimmet, "The metabolic syndrome," Lancet, vol. 375, pp. 181-3, Jan 16 2010.
J. Elovson, J. E. Chatterton, G. T. Bell, V. N. Schumaker, M. A. Reuben, D. L. Puppione, et al., "Plasma very low density lipoproteins contain a single molecule of apolipoprotein B," J Lipid Res, vol. 29, pp. 1461-73, Nov 1988.
E. S. Ford, "Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence," Diabetes Care, vol. 28, pp. 1769-78, Jul 2005.
S. M. Grundy, J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, et al., "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement," Circulation, vol. 112, pp. 2735-52, Oct 25 2005.
B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, et al., "Cardiovascular morbidity and mortality associated with the metabolic syndrome," Diabetes Care, vol. 24, pp. 683-9, Apr 2001.
F. Jing, Y. Mao, J. Guo, Z. Zhang, Y. Li, Z. Ye, et al., "The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study," Lipids Health Dis, vol. 13, p. 81, May 14 2014.
C. H. Jung, J. Y. Hwang, J. H. Yu, M. S. Shin, S. J. Bae, J. Y. Park, et al., "The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population," Clin Endocrinol (Oxf), vol. 77, pp. 699-706, Nov 2012.
S. W. Kim, J. H. Jee, H. J. Kim, S. M. Jin, S. Suh, J. C. Bae, et al., "Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1," Int J Cardiol, vol. 168, pp. 2678-83, Oct 3 2013.
P. Kocelak, J. Chudek, and M. Olszanecka-Glinianowicz, "Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria," Minerva Endocrinol, vol. 37, pp. 247-54, Sep 2012.
H. M. Lakka, D. E. Laaksonen, T. A. Lakka, L. K. Niskanen, E. Kumpusalo, J. Tuomilehto, et al., "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men," Jama, vol. 288, pp. 2709-16, Dec 4 2002.
J. M. Lee, M. J. Okumura, M. M. Davis, W. H. Herman, and J. G. Gurney, "Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study," Diabetes Care, vol. 29, pp. 2427-32, Nov 2006.
J. C. Levy, D. R. Matthews, and M. P. Hermans, "Correct homeostasis model assessment (HOMA) evaluation uses the computer program," Diabetes Care, vol. 21, pp. 2191-2, Dec 1998.
Z. Makaridze, E. Giorgadze, and K. Asatiani, "Association of the Apolipoprotein B/Apolipoprotein A-I Ratio, Metabolic Syndrome Components, Total Cholesterol, and Low-Density Lipoprotein Cholesterol with Insulin Resistance in the Population of Georgia," International Journal of Endocrinology, vol. 2014, p. 8, 2014.
N. M. McKeown, J. B. Meigs, S. Liu, E. Saltzman, P. W. Wilson, and P. F. Jacques, "Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort," Diabetes Care, vol. 27, pp. 538-46, Feb 2004.
A. M. McNeill, W. D. Rosamond, C. J. Girman, S. H. Golden, M. I. Schmidt, H. E. East, et al., "The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study," Diabetes Care, vol. 28, pp. 385-90, Feb 2005.
C. Pitsavos, D. B. Panagiotakos, J. Skoumas, L. Papadimitriou, and C. Stefanadis, "Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study," Angiology, vol. 59, pp. 335-41, Jun-Jul 2008.
H. Q. Qu, Q. Li, A. R. Rentfro, S. P. Fisher-Hoch, and J. B. McCormick, "The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning," PLoS One, vol. 6, p. e21041, 2011.
S. M. Rossner, M. Neovius, A. Mattsson, C. Marcus, and S. Norgren, "HOMA-IR and QUICKI: decide on a general standard instead of making further comparisons," Acta Paediatr, vol. 99, pp. 1735-40, Nov 2010.
P. A. Sarafidis, A. N. Lasaridis, P. M. Nilsson, M. I. Pikilidou, P. C. Stafilas, A. Kanaki, et al., "Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes," J Hum Hypertens, vol. 21, pp. 709-16, Sep 2007.
J. Sierra-Johnson, A. Romero-Corral, V. K. Somers, F. Lopez-Jimenez, G. Walldius, A. Hamsten, et al., "ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects," Eur Heart J, vol. 28, pp. 2637-43, Nov 2007.
J. Sierra-Johnson, V. K. Somers, F. H. Kuniyoshi, C. A. Garza, W. L. Isley, A. S. Gami, et al., "Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome," Am J Cardiol, vol. 98, pp. 1369-73, Nov 15 2006.
A. D. Sniderman, "The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndrome," Eur Heart J, vol. 28, pp. 2563-4, Nov 2007.
A. D. Sniderman, T. Scantlebury, and K. Cianflone, "Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus," Ann Intern Med, vol. 135, pp. 447-59, Sep 18 2001.
G. Walldius and I. Jungner, "The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence," J Intern Med, vol. 259, pp. 493-519, May 2006.
K. H. Yi, J. S. Hwang, E. Y. Kim, S. H. Lee, D. H. Kim, and J. S. Lim, "Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: A population-based study," Diabetes Res Clin Pract, vol. 103, pp. 106-13, Jan 2014.
J. Yin, M. Li, L. Xu, Y. Wang, H. Cheng, X. Zhao, et al., "Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers," Diabetol Metab Syndr, vol. 5, p. 71, Nov 15 2013.
Q. Yin, X. Chen, L. Li, R. Zhou, J. Huang, and D. Yang, "Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome," J Obstet Gynaecol Res, vol. 39, pp. 203-9, Jan 2013.
X. Ying, Y. Qian, Y. Jiang, Z. Jiang, Z. Song, and C. Zhao, "Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity," Acta Diabetol, vol. 49, pp. 465-72, Dec 2012.
A. Zachurzok-Buczynska, K. Klimek, M. Firek-Pedras, and E. Malecka-Tendera, "Are metabolic syndrome and its components in obese children influenced by the overweight status or the insulin resistance?," Endokrynol Pol, vol. 62, pp. 102-8, 2011.
J. Zhang, P. Fan, H. Liu, H. Bai, Y. Wang, and F. Zhang, "Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS," Hum Reprod, vol. 27, pp. 2484-93, Aug 2012.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
